Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muiesan, G.
Right arrow Articles by Motolese, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muiesan, G.
Right arrow Articles by Motolese, M.
(Chest. 1969;55:18-24.)
© 1969 American College of Chest Physicians

A Controlled Study of Three Respiratory Stimulants in Chronic Respiratory Failure

Giulio Muiesan M.D.1; Carlo Augusto Sorbini M.D.1; Vittorio Grassi M.D.1; Eugenio Solinas M.D.1; Giovanni Casucci M.D.1; Eugenio Petz M.D.1; and Mario Motolese M.D.2

1 Institute of Medical Pathology, University of Perugia, Perugia, Italy
2 Second Medical Clinic, University of Rome, Rome, Italy

The effects of slow intravenous infusion of three different respiratory stimulants (dimefline, nikethamide and prethcamide) on minute and alveolar ventilation, blood gases and pH were studied in 18 patients with chronic pulmonary emphysema and chronic respiratory failure. For a more accurate assessment of the results of the double blind controlled trial, a factorial design in a Youden square scheme was employed. Respiratory rate, tidal volume, minute ventilation, arterial Po2, pH and heart rate failed to show significant changes after the intravenous infusion of the drugs. The other parameters studied (dead space, alveolar ventilation, CO2 output, Paco2) showed some differences but these were temporally similar for the three drugs. As improvement in respiratory and blood gases data was transient and slight and undersirable side-effects constant, it is concluded that the use of respiratory stimulants in management ofchronic respiratory failure cannot be recommended.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1969 by the American College of Chest Physicians.